Metropolis Healthcare Q2 profit jumps 42.7% YoY

Metropolis Healthcare reported a 42.7% rise in Q2 profit, and the stock now trades near the top of its Rs 510 to Rs 610 range. Metropolis Healthcare Limited [

] rose 2.21% to close at Rs 581.25 on 4 November 2026, led by its Q2 numbers. Consolidated profit rose 42.7% to Rs 75.5 crore from Rs 52.9 crore a year ago. Revenue grew 15.8% to Rs 496.8 crore from Rs 429.2 crore. The stock closed higher in 7 of the last 8 sessions and has gained over 11% in this period. On the daily chart, price has stayed in a range of Rs 510 to Rs 610 for about six months. Momentum improved after 22 October 2026, and the stock is now trading in the upper half of this range, about 5% below the range high. What next: Rs 610 is the resistance, with the highest print at Rs 609.05. A breakout above it with higher volume may extend the momentum. If price turns lower from here, Rs 510 is the range support to watch. Conclusion: Strong earnings and a rally of over 11% have taken price near the top of its range. A move beyond Rs 610 or below Rs 510 may set the next direction. Disclaimer: I, Akhilesh Jat (SEBI RA Reg. No. INH000016649), do not hold any position in the stock discussed. This content is informational, not a recommendation. Investments in securities are subject to market risks. Read all related documents carefully before investing.